/PHARM.ST
PHARM.ST Stock - Pharmiva AB (publ)
Healthcare|BiotechnologySTO
$0.56-16.17%
$0.11 (-16.17%) • Nov 17
46
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.0
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).70
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.58
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+10.0%upside
Target: $0.62
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for PHARM.ST
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$0.55 – $0.57
TARGET (TP)$0.64
STOP LOSS$0.52
RISK/REWARD1:2.0
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta1.56
52W High$2.32
52W Low$0.56
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|
| Revenue | $2.63M | $248,000 | $1.03M | $2.49M |
| Gross Profit | $2.59M | $2.21M | $723,000 | $5.32M |
| Gross Margin | 98.4% | 892.7% | 69.9% | 213.8% |
| Operating Income | $-23,668,000 | $-20,762,000 | $-13,958,000 | $-9,725,000 |
| Net Income | $-23,676,000 | $-20,764,000 | $-14,054,000 | $-9,871,000 |
| Net Margin | -900.9% | -8372.6% | -1357.9% | -396.9% |
| EPS | $-1.36 | $-2.80 | $-1.75 | $-1.23 |
Company Overview
Pharmiva AB (publ) engages in the research and development of medical products. The company develops Vernivia, an over-the-counter vaginal mousse for the treatment of bacterial vaginosis. The company is based in Lund, Sweden.
Visit WebsiteLoading analyst ratings...
Earnings History & Surprises
PHARM.STBeat Rate
100%
Last 2 quarters
Avg Surprise
+26.1%
EPS vs Estimate
Beats / Misses
2/0
Last 12 quarters
Latest EPS
$-0.35
Q2 2023
EPS Surprise History
Q4 21
No data
Q1 22
+22.8%
$-0.71vs$-0.92
Q2 22
+29.4%
$-0.77vs$-1.09
Q2 22
No data
Q3 22
No data
Q4 22
No data
Q1 23
No data
Q2 23
No data
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q2 2023 | Jun 30, 2023 | — | $-0.35 | — | — |
Q1 2023 | Mar 31, 2023 | — | $-0.31 | — | — |
Q4 2022 | Dec 31, 2022 | — | $-0.36 | — | — |
Q3 2022 | Sep 30, 2022 | — | $-0.49 | — | — |
Q2 2022 | Jun 30, 2022 | — | $-0.80 | — | — |
Q2 2022 | May 11, 2022 | $-1.09 | $-0.77 | +29.4% | ✓ BEAT |
Q1 2022 | Feb 24, 2022 | $-0.92 | $-0.71 | +22.8% | ✓ BEAT |
Q4 2021 | Nov 18, 2021 | — | $-0.67 | — | — |
Q3 2021 | Aug 19, 2021 | — | $-0.56 | — | — |
Q2 2021 | May 20, 2021 | — | $-1.01 | — | — |
Q1 2021 | Feb 15, 2021 | — | $-0.45 | — | — |
Q4 2020 | Dec 31, 2020 | — | $-0.51 | — | — |
Q2 2020 | Jun 30, 2020 | — | $-0.36 | — | — |
Q1 2020 | Mar 31, 2020 | — | $-0.42 | — | — |
Latest News
Loading news...
Frequently Asked Questions about PHARM.ST
What is PHARM.ST's current stock price?
Pharmiva AB (publ) (PHARM.ST) is currently trading at $0.56 per share. The stock has moved -16.17% today.
What is the analyst price target for PHARM.ST?
No analyst price targets are currently available for this stock.
What sector is Pharmiva AB (publ) in?
Pharmiva AB (publ) operates in the Healthcare sector, specifically within the Biotechnology industry. The company is traded on the STO exchange.
What is PHARM.ST's market cap?
Pharmiva AB (publ) has a market capitalization of $0.01 billion, making it a small-cap company.
Does PHARM.ST pay dividends?
No, Pharmiva AB (publ) does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorAEGIR.ST
AegirBio AB (publ)
$0.43
Mkt Cap: $0.0B
AMNI.ST
Amniotics AB (publ)
$0.01
Mkt Cap: $0.0B
CYXO.ST
Cyxone AB (publ)
$0.02
Mkt Cap: $0.0B
DIABIO.ST
Diagonal Bio AB (publ)
$0.01
Mkt Cap: $0.0B
IDOGEN.ST
Idogen AB (publ)
$0.12
Mkt Cap: $0.0B
L2S.ST
Learning 2 Sleep L2S AB (publ)
$0.02
Mkt Cap: $0.0B
PEXAB.ST
Pexa AB
$0.25
Mkt Cap: $0.0B
PHLOG-B.ST
Pharmacolog i Uppsala AB (publ)
$0.10
Mkt Cap: $0.0B
VSDB.ST
VibroSense Dynamics AB
$0.75
Mkt Cap: $0.0B
ZICC.ST
Ziccum AB (publ)
$0.25
Mkt Cap: $0.0B
Explore stocks similar to PHARM.ST for comparison